🔎 Trials Near Me

Utama › Obesiti › Texas › Houston

Kajian klinikal Obesiti di Houston, TX

43 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Mengambil pesertaFasa 2
  • Cardiovascular Specialists of Willowbrook, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Mengambil pesertaFasa 3
  • PlanIt Research, PLLC, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Mengambil pesertaFasa 3
  • DM Clinical, Houston
Umur 8 hingga 18 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Mengambil pesertaFasa 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Mengambil pesertaFasa 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Mengambil pesertaFasa 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • dan 1 lagi
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Mengambil pesertaFasa 3
  • Juno Research, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Mengambil pesertaFasa 3
  • Juno Research, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • dan 2 lagi
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Mengambil pesertaFasa 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Mengambil pesertaFasa 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Mengambil pesertaFasa 2
  • PlanIt Research, PLLC, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
  • The University of Texas Health Science Center at Houston, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Mengambil pesertaFasa 3
  • AURORA-2 Clinical Site, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • dan 3 lagi
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Mengambil pesertaFasa 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Mengambil pesertaFasa 2
  • Juno Research, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Mengambil pesertaFasa 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Umur 18 hingga 79 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Mengambil pesertaFasa 2
  • PlanIt Research, PLLC, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Mengambil pesertaFasa 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Mengambil pesertaFasa 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Mengambil pesertaFasa 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Bellaire · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Mengambil pesertaFasa 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Mengambil pesertaFasa 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Umur 18 hingga 99 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Mengambil pesertaFasa 2
  • Baylor Texas Children's Hospital, Houston
Umur 7 hingga 25 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mengambil pesertaFasa 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Mengambil pesertaFasa 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Umur 18 hingga 79 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07654361

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Children's Nutrition Research Center, Houston
Umur 12 hingga 18 · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06959901

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Mengambil pesertaSukarelawan sihat dialu-alukanMenyebut bayaran untuk peserta
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Umur 14 hingga 16 · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06943001

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Lilli Health, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Mei 2026 · NCT05950282

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Mengambil peserta
  • M D Anderson Cancer Center, Houston
Umur 18 ke atas · Wanita · Dikemas kini 21 Apr 2026 · NCT04003038

Incretin Microdosing for Cardiometabolic Health in People With HIV

Mengambil pesertaFasa 2
  • The University of Texas Health Science Center at Houston, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07325500

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Mengambil pesertaFasa 2
  • Baylor College of Medicine, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jan 2026 · NCT06273072

RESET System Pivotal Trial (Rev F)

Mengambil peserta
  • Baylor College of Medicine, Houston
Umur 22 hingga 65 · Semua jantina · Dikemas kini 18 Jul 2024 · NCT04101669

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Mengambil peserta
  • Houston Methodist Hospital, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Apr 2024 · NCT06339320

Kajian Obesiti di bandar lain

Kajian lain di Houston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.